Nan Ji

Dr Nan Ji is President and CEO of PAQ Therapeutics. He is a prolific inventor and discoverer, with more than 30 patent applications filed. With three years spent at Kymera Therapeutics from the time the company was in its seed stage, he is also an expert at building an organization from the ground up. At Kymera, Dr Ji served as Vice President of Chemistry and played significant roles in driving the company scientific strategies, platform-building activities, and business development, as well as external collaborations crucial to the company’s success in targeted protein degradation technology. Before Kymera, Dr Ji spent 2 years at Mitobridge (now part of Astellas), where he was responsible for its NAD+-boosting portfolio with multiple approaches to modulate mitochondrial functions. Prior to that, he spent 7+ years at Novartis, where he contributed to and delivered multiple clinical and preclinical development candidates. Dr Ji earned his PhD in organic chemistry from Harvard University.